The accessibility of activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to damaged blood vessels or atherosclerotic plaques is likely to play a crucial role in subsequent platelet recruitment. To define better the factors involved in this process, we developed a functional assay to assess the presence of activated, luminal GPIIb /IIIa receptors, based on their ability to bind erythrocytes containing a high density of covalently coupled RGD-containing peptides (thromboerythrocytes). Platelets readily adhered to wells coated with purified type I rat skin collagen and the adherent platelets bound a dense lawn of thromboerythrocytes. With fibrinogen-coated wells, platelet adhesion increased as the fibrinogen-coating concentration increased, reaching a plateau at about 11 ug /ml. ( 16, 17, 18, (27) (28) (29) , but their contributions to platelet adhesion are less well defined.
Introduction
The accessibility of activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to damaged blood vessels or atherosclerotic plaques is likely to play a crucial role in subsequent platelet recruitment. To define better the factors involved in this process, we developed a functional assay to assess the presence of activated, luminal GPIIb /IIIa receptors, based on their ability to bind erythrocytes containing a high density of covalently coupled RGD-containing peptides (thromboerythrocytes). Platelets readily adhered to wells coated with purified type I rat skin collagen and the adherent platelets bound a dense lawn of thromboerythrocytes. With fibrinogen-coated wells, platelet adhesion increased as the fibrinogen-coating concentration increased, reaching a plateau at about 11 ug /ml.
Thromboerythrocyte binding to the platelets adherent to fibrinogen showed a paradoxical response, increasing at fibrinogen coating concentrations up to -4-6 $g/ml and then dramatically decreasing at higher fibrinogen-coating concentrations. Scanning electron microscopy demonstrated that the morphology of platelets adherent to collagen was similar to that of platelets adherent to low density fibrinogen, with extensive filopodia formation and ruffling. In contrast, platelets adherent to high density fibrinogen showed a bland, flattened appearance. Immunogold staining of GPIIb/IIIa receptors demonstrated concentration of the receptors on the filopodia, and depletion of receptors on the flattened portion of the platelets. Thus, there is a paradoxical loss of accessible, activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to high density fibrinogen. Two factors may contribute to this result: engagement of GPIIb/IIIa receptors with fibrinogen on the abluminal surface leading to the loss of luminal receptors, and loss of luminal filopodia that interact with thromboerythrocytes. These data provide insight into the differences in thrombogenicity between surfaces, and may provide a mechanism for purposefully passivating platelet-reactive artificial surfaces. ( After injury to normal blood vessels or atherosclerotic lesions, platelets rapidly adhere to the damaged surface. This process is thought to be mediated by platelet receptors that have high affinity for the adhesive proteins present in normal blood vessel walls and atherosclerotic plaques (1) (2) (3) . Considerable evidence supports an important role for the interactions between platelet GPIb with vWf (1) (2) (3) (4) (5) (6) and GPIIb/IIIa (allb3) with vWf and fibrinogen, as well as perhaps fibronectin, thrombospondin, and/or vitronectin (1) (2) (3) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Some evidence supports a role for GPIa/IIa (a2f31) with collagen ( [19] [20] [21] ). Other receptor-ligand interactions have been identified, including GPIV (CD36) with collagen (22) and thrombospondin (23) , GPIc*/ Ila (a5f1) with fibronectin (24) , GPIc/IIa (a6fl1) (25) and a 67,000-Mr glycoprotein (26) with laminin, and aCfl3 with vitronectin, fibrinogen, thrombospondin, fibronectin and vWf ( 16, 17, 18, (27) (28) (29) , but their contributions to platelet adhesion are less well defined.
The ability of the adherent platelets to recruit additional layers of platelets via platelet aggregation plays a crucial role in determining the outcome of injury to a normal blood vessel. Thus, although a single layer of platelets may be sufficient to prevent hemorrhage from minimal trauma, it is unlikely to arrest bleeding produced by serious damage to the blood vessel. The platelet recruitment process is equally important in diseased blood vessels. Thus, if the platelet response to rupture of an atherosclerotic plaque is limited to the deposition ofa platelet monolayer, there is minimal risk of vaso-occlusion, whereas, if florid platelet thrombus formation occurs, the risks of thromboembolization, vaso-occlusion, and ischemic infarction are dramatically increased.
The processes that determine whether platelet adhesion results in a platelet monolayer or platelet thrombus formation are poorly understood. Factors that are likely to affect the outcome include the biochemical nature of the exposed surface; the rheologic conditions (shear rate, flow patterns, presence of erythrocytes) (30) ; the biochemical integrity of the platelets (surface receptors, activation pathways, granule contents); and the presence of platelet agonists (e.g., ADP, epinephrine, thrombin, thromboxane A2, serotonin, and vasopressin), plasma cofactors (fibrinogen, vWfand perhaps fibronectin and vitronectin), and other modifying influences [(PGI2 (31 ) , nitric oxide (31 ), ecto-ADPase (32), and cooperative biochemical interactions with erythrocytes (33) and leukocytes (34) ].
Since current evidence indicates that platelet-platelet interactions are primarily mediated by the simultaneous binding of the multivalent adhesive glycoproteins fibrinogen and/or vWf to GPIIb/IIIa receptors on two different platelets (35) , all of the factors listed above must ultimately operate by affecting the ability ofGPIIb/II1a receptors on an adherent platelet to either capture, or serve as a docking site for, a circulating platelet. To be more precise, since the GPIIb/IIIa receptor must be activated in order to bind the adhesive glycoproteins with high affinity, and since newly recruited platelets can only bind to the luminal surface ofadherent platelets, the presence ofphysically accessible, activated, GPIIb/IIIa receptors on the luminal surface ofadherent platelets is a prerequisite for platelet thrombus formation.
Although it is possible to devise assays involving two separate layers ofplatelets to assess the presence ofactivated GPIIb/ I11a receptors on the luminal surface ofadherent platelets, such assays are technically cumbersome, and it is difficult to be certain that the second layer of platelets is binding exclusively to the first layer of platelets; moreover, the activation state of the GPIIb/IIIa receptors on the platelets in the second layer is difficult to control, as is their release of adhesive glycoproteins and platelet-activating agents. As a result, we have developed an assay based on the ability of adherent platelets to bind our previously described thromboerythrocytes (36) . Thromboerythrocytes are red blood cells with approximately one million peptides containing the RGDF sequence covalently coupled to their surface (36) . As we previously reported, the length of the RGD-containing peptide was chosen so that the thromboerythrocytes would bind to activated GPIIb/IIIa receptors on platelets, but not unactivated receptors (36, 37) . Thus, the binding ofthromboerythrocytes to a lawn ofadherent platelets should be a direct reflection of the accessibility of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets.
Methods
Materials. Our preparation ofpurified, type I collagen from the skin of lathyritic rats was previously described (21 ) . The collagen was stored in 3% acetic acid. Fibrinogen was purified from plasma by sequential precipitations with 0.9 M glycine (50C) and then 0.4 M glycine. Band I fibrinogen was purified from the supernatant as previously described (38) , and then fraction 1-3 was purified as per Blomback and Blomback (39) . The final material was chromatographed on Sepharose CL-6B (Pharmacia, LKB Biotechnology, Inc., Piscataway, NJ) to remove any high molecular weight soluble fibrin. The fibrinogen had no detectable vWf, vitronectin, or fibronectin asjudged by immunoblotting. For some studies, the fibrinogen ( 1.1-2.5 mg) was radiolabeled with 1251 using 25 jug of immobilized Iodogen (Pierce Biochemical Co., Rockford, IL); the specific activity was 500-2,500 cpm/ng. BSA (fraction V) was obtained from Sigma Chemical Co., St. Louis, MO. Purified mAbs lOE5 (anti-GPIIb/IIIa; reference 40), 7E3 (anti-GPIIb/IIIa + aI3; reference 41), and 6D1 (anti-GPIb; reference 42) have previously been described. Platelet preparation. Whole blood was anticoagulated with ACD (8.5:1.5) and platelet-rich plasma (PRP) was prepared by centrifugation at 700 g for 3.5 min at 22°C. After adding 0.1 vol of additional ACD, the PRP was centrifuged at 2,100 g for 10 min at 22°C and the platelet pellet was incubated with Na25"CrO4 for 60 min at 37°C. The platelets were separated from the free 5'Cr by gel-filtration on Sepharose-2B (Pharmacia LKB Biotechnology, Inc.) using 0.15 M NaCI, 0.05 M Tris/HCI, 0.5% BSA, 10 mM glucose, pH 7.4. MgCl2, which supports adhesion of gel-filtered platelets to collagen better than calcium ( 19, 21 ) and also supports ligand binding to GPIIb/IIIa, was then added to the gel-filtered platelets to achieve a final concentration of 2 mM.
Thromboerythrocytes. Thromboerythrocytes were prepared as previously described by crosslinking the peptide AcCGGRGDF-NH2 to washed erythrocytes using the heterobifunctional cross-linking agent mal-sac-HNSA (Bachem Bioscience Inc., Philadelphia, PA) (36 To assess the ability of adherent platelets to bind a second layer of platelets as a function of the fibrinogen-and collagen-coating concentrations, the assay was modified and performed in duplicate; one well received radiolabeled platelets and thromboerythrocytes as before, and the other well received a first layer of unlabeled platelets, a subsequent 1-h incubation with platelet-poor plasma (to supply adhesive glycoproteins), and finally a second layer of radiolabeled platelets (1 h). Thus, the radioactivity in the first well reflected the binding ofthe first layer of platelets, whereas the radioactivity in the second well reflected the binding of the second layer.
Scanning electron microscopy. The adhesion assay was conducted as described above in 96-well polystyrene microtiter plates composed of removable 8-well strips (no. 2580; Costar Corp., Cambridge, MA). After the assays were completed, the wells were rinsed once with PBS (0.15 M NaCl, 0.01 M NaPO4, pH 7.4) and then the cells in the wells were fixed with 100 ,l 1.5% glutaraldehyde (LADD-Research Industries, Burlington, VT), 2% paraformaldehyde (Aldrich Chemical Co., Inc., Milwaukee, WI) in 0. 33 gg/ml, and these adherent platelets are able to bind a layer of thromboerythrocytes (36) . The surface density of both platelets and thromboerythrocytes was similar when the wells were coated with 3.3 gg/ml of collagen rather than 33 ,ug/ml. In sharp contrast, over a similar range offibrinogen concentrations used for coating the wells, both the ability of platelets to adhere to the wells and the ability ofthe adherent platelets to bind thromboerythrocytes differed dramatically as a function ofthe fibrinogen concentration. Platelet adhesion increased as the concentration of fibrinogen used to coat the wells increased from -1.5-11 ,ug/ml; above this concentration of fibrinogen there was little or no additional increase in platelet adhesion, even at 33 and 100 Mg/ml (Fig. 2) . At the higher fibrinogen concentrations, the density of adherent platelets was very similar to that obtained with collagen, suggesting that this represents a near maximal density for a monolayer. Thromboerythrocyte binding to the platelets adherent to fibrinogen also differed as a function ofthe fibrinogen concentration used to coat the wells, but the pattern did not follow that observed with platelets. The number of thromboerythrocytes bound per well increased as the fibrinogen-coating concentration increased from 1. 5-4.6 ,gg/ml, plateaued in the range between 4.6-6.2 ug/ml, and then declined at higher fibrinogen-coating concentrations. At the highest fibrinogen-coating concentrations, the number of bound thromboerythrocytes was very low, averaging less than 5% of the value obtained at 4.6 jug/ml. This pattern of thromboerythrocyte binding was reproducible from experiment to experiment and with different platelet donors, although there were minor variations in the fibrinogen concentration producing the peak value of thromboerythrocyte binding: In the 18 separate experiments, peak thromboerythrocyte binding occuffed at 6.2 ,gg/ml fibrinogen in 8 experiments, at 4.6 ,gg/ml in 7 experiments, and at 8.3 ,gg/ml, 3.5 Ag/ml, and 2.6 ,ug/ml in 1 experiment each. Although the possibility was considered that thromboerythrocyte binding was inhibited at the higher fibrinogen-coating concentrations because of the increased density of adherent platelets, this hypothesis was considered unlikely because platelets adherent to collagen at a similarly high density were very effective in binding thromboerythrocytes.
Inhibition ofthromboerythrocyte binding to adherent platelets by m,4bs. We previously demonstrated that mAb lOE5, directed against the GPIIb/IIIa receptor, and an RGD-containing soluble peptide could inhibit the binding of thromboerythrocytes to platelets adherent to collagen-coated microtiter wells (36) . This supported the hypothesis that thromboerythrocyte binding is specifically mediated by the interaction 1. Abbreviations used in this paper: BET, backscatter emitted images; SEI, secondary emitted images. 2798 Coller, Kutok, Scudder, Galanakis, West, Rudomen, and Springer between the RGD-containing peptides on the surface of the thromboerythrocytes and the luminal GPIIb/IIIa receptors on the adherent platelets. Our new assay permits us to quantify these observations and to assess whether similar results are obtained with platelets adherent to fibrinogen. As shown in Fig. 3 , antibody 6D 1, directed against the GPIb receptor, had no effect on thromboerythrocyte binding. In contrast, adding 50 ,4g/ml antibody IOE5, directed against GPIIb/IIIa, to platelets after they adhered to the microtiter wells caused profound inhibition ofsubsequent thromboerythrocyte binding to platelets adherent to either fibrinogen (84% inhibition at 4.6 ig/ml) or collagen (76% inhibition at 33 pg/ml). Antibody 7E3, directed against GPIIb/IIIa + a°I33, produced virtually complete inhibition of thromboerythrocyte binding to platelets adherent to either adhesive protein (> 99% in both cases). The inhibition caused by 1OE5 and 7E3 was not a result of detaching platelets from the surface, since the densities ofadherent platelets at the concentrations indicated in Fig. 3 A maximal value was observed at 2.0 ,g/ml; using higher fibrinogen-coating concentrations resulted in a progressive decrease in the ability of the adherent platelets to bind thromboerythrocytes, with the values dropping nearly to zero at the highest concentrations. The dependence of thromboerythrocyte binding on the fibrinogen-coating concentration was further explored by directly assessing the number of molecules of fibrinogen bound per well, and then calculating the number of fibrinogen molecules that would be expected to be under a fully spread platelet, estimated to be -25 ,um2 from our scanning electron micrographs (see below). Studies with radiolabeled fibrinogen demonstrated that the percentage of added fibrinogen that bound per well decreased as the concentration of added fibrinogen increased, going from -46% at 1-22 ,gg/ml to -32% at 33 gg/ml, and -15% at 100 ,gg/ml. Analysis ofthe bound fibrinogen as a function ofthe surface area coated, led to the determination that at the 100 jug/ml fibrinogen-coating concentration, more than 700,000 fibrinogen molecules would be expected to be underneath a fully spread platelet, whereas at 2 ,g/ml, only -20,000 fibrinogen molecules would be beneath a spread platelet (Fig. 4) . Since the number ofsurface GPIIb/IIIa receptors per platelet is probably -40,000-80,000 (40, 43, 44) , with perhaps another 20,000-40,000 receptors in internal stores (41, 45) , it is interesting to note that the marked reduction in the ability of adherent platelets to support thromboerythrocyte binding occurs as the number of fibrinogen molecules under a spread platelet exceeds the number ofGPIIb/IIIa receptors (Fig. 4) .
Assessment of the ability of adherent platelets to bind a second layer ofplatelets. As Collagen (Ag/ml) Figure 3 . Effect of mAbs on thromboerythrocyte binding to adherent platelets. The adhesion assay was conducted as described in Methods except that mAbs 6D1 (anti-GPIb), 10E5 (anti-GPIIb/IIIa), or 7E3 (anti-GPIIb/IIIa + a,03) were incubated with the platelets after platelet adhesion and throughout the thromboerythrocyte binding step. In this representative experiment, the control was similar to that depicted in Fig. 2 Fig. 2 were used to calculate the number of thromboerythrocytes bound per platelet for the different collagen-and fibrinogen-coating concentrations. In three separate experiments, '23I-labeled fibrinogen was used to determine the amount of fibrinogen bound per well at the different fibrinogen-coating concentrations; from these data the number of fibrinogen molecules bound per 25 gm2, the area estimated to be under a fully spread platelet, was calculated. For collagen, the number of thromboerythrocytes bound per platelet was similar at collagen-coating concentrations of 3.3 and 33 gg/ml, whereas the number of thromboerythrocytes bound per platelet was highest at a fibrinogen-coating concentration of -2 ug/iml and showed a steady downward progression at higher fibrinogen-coating concentrations. The number of fibrinogen molecules per 25 Mm2 was -700,000 at a fibrinogencoating concentration of 100 Mg/ml, 200,000 at -9 9,g/ml, 100,000 at -4 Ag/ml, and -20,000 at 2 gg/ml. ment depicted in Fig. 5 , the adhesion of the first layer of platelets and the binding of the thromboerythrocytes followed the same pattern as shown in Fig. 2 . The binding of the second layer ofplatelets to the adherent platelets incubated with platelet-poor plasma, followed a pattern similar to that observed with the thromboerythrocytes, with peak binding to platelets adherent to wells coated with fibrinogen at 4.6 ug/ml and a decrease in binding at the higher fibrinogen-coating concentrations. The decrease in the binding of the second layer of platelets at the higher fibrinogen-coating concentrations was not, however, as dramatic as the decrease in thromboerythrocyte binding in this experiment, although it did approximate the mean values depicted in Fig. 2 . The binding ofthe second layer of platelets to platelets adherent to collagen also followed the same pattern observed with thromboerythrocytes, with high density binding to platelets adherent to wells coated with either 3.3 or 33 gg/ml. In addition, as with the thromboerythrocytes, the density ofbinding ofthe second layer ofplatelets was higher when collagen was the substrate than when fibrinogen was the substrate. When purified fibrinogen at concentrations between 150-500 ug/ml was substituted for platelet-poor plasma as the solution used to interact with the already adherent platelets, the same biphasic pattern of second layer platelet binding was also observed (data not shown). Scanning electron microscopy. The morphology ofplatelets adherent to collagen at 1 gg/ml and 33 Aug/ml was essentially the same, with extensive membrane ruffling and filopodia formation, and extension of the filopodia from the central region of the platelet both along the surface of the well and up from the surface into the equivalent of the luminal space (Fig. 6 A) .
Thromboerythrocytes were readily seen binding to the platelets adherent to collagen, and binding appeared to be primarily due to attachment of filopodia extending up from the surface ofthe well onto the surface of the thromboerythrocytes. At a low fibrinogen-coating concentration (1 ,ug/ml), the morphology ofadherent platelets was similar to that observed with collagen at both low and high coating concentrations (Fig. 6 B The adhesion assay was performed in duplicate: one plate was used to assess platelet adhesion and thromboerythrocyte binding as described in Methods; in the other plate, the assay was modified so that unlabeled platelets were used in the initial adhesion step, plasma was then incubated with the adherent first layer of platelets, and finally a second layer of 31Cr-labeled platelets was allowed to bind to the first layer of adherent platelets. In this experiment, the adhesion of the first layer of platelets and thromboerythrocyte binding were similar to that observed in Fig. 2 (33 jtg/ml) and low density fibrinogen (4 jsg/ml) bound antibody lOE5 (anti-GPIIb/IIIa) readily, with the filopodia staining most intensely (Fig. 7 A) . Platelets that had attached and spread on high density fibrinogen (100 jg/ml), however, showed very little binding of lOE5 to the spread surface ofthe platelets and virtually all ofthe binding was confined to the few regions where small ruffles and filopodia could be identified (Fig. 7 B) . To assess whether the apparent absence of GPIIb/ lIIa antigen from the spread region of the platelet was specific, the binding of antibody 6D1 (anti-GPIb) was also tested. It bound extensively to the spread surface of the platelets adherent to the high density fibrinogen, indicating that loss of GPIIb/IIIa antigen was not part ofa nonspecific receptor reaction to spreading on high density fibrinogen (Fig. 7 B) . It also demonstrated that spreading on the high density fibrinogen did not produce a generalized loss of accessibility of receptors to mAbs. The experiments in Fig. 7 were performed by incubating the adherent platelets with the mAbs and then gently fixing the platelets before adding the gold-labeled second antibody. Similar results were observed when the gentle fixation was performed before the first antibody was added (data not shown).
Discussion
Although the accessibility of activated, GPIIb/IIIa receptors on the surface of adherent platelets plays an important role in hemostasis and thrombosis, technical complexity has made it a difficult phenomenon to study. Savage et al. studied the adhesion of platelets in PRP prepared from blood anticoagulated with the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone dihydrochloride (PPACK) to microtiter wells coated with fibrinogen or vWf at a single concentration (50 ofFc receptors on the macrophages. They went on to show that loss of luminal receptors was due to lateral diffusion of receptors in the membrane, a process that was sensitive to temperature, but not cytoskeletal-disrupting agents, metabolic inhibitors, or even fixation with low doses of formaldehyde (57) . The diffusion process was extremely rapid, being nearly complete in 2 min at 370C. We found a remarkable difference in the morphology ofthe platelets adherent to the high density fibrinogen as compared to the low density fibrinogen. With the low density fibrinogen, the platelets had extensive filopodia and ruffling extending both onto the surface of the well and extending up from the surface. This morphology was very similar to that observed with platelets adherent to collagen. In contrast, the platelets adherent to high density fibrinogen were spread flat, with the rounded protrusion ofthe organelles in the center giving a fried egg appearance. We speculate that the larger number ofGPIIb/ I11a receptors that are able to tack down the platelets on the high density fibrinogen contribute to the appearance, with the possibility that other spreading mechanisms are also triggered as a result of the interactions. Our direct assessment of adherent platelets for GPIIb/IIIa antigen with mAbs and immunogold reagents demonstrated concentration of GPIIb/IIIa receptors on filopodia and ruffled areas of platelets adherent to collagen or low density fibrinogen, and depletion ofGPIIb/IIIa on the flattened surfaces of the platelets adherent to the high density fibrinogen. The latter depletion was specific for GPIIb/ Ila, since an antibody to GPIb showed strong reactivity over the flattened surfaces of the platelets adherent to high density fibrinogen.
These morphologic and immunologic studies add another dimension to our analysis of the paradoxical loss of thromboerythrocyte binding to platelets adherent to high density fibrinogen. Since we observed that platelets bind thromboerythrocytes via their filopodia, it is possible that even if surface GPIIb/ I11a receptors are retained on the luminal surface ofthe adherent platelets, the absence of filopodia and ruffling limits thromboerythrocyte, and perhaps platelet, binding.
In summary, in this study we have begun a systematic analysis of the biochemical and morphological changes in platelets after adhesion to fibrinogen and collagen. These changes affect their ability to make activated GPIIb/IIIa receptors accessible on the luminal surface in a way that allows for the recruitment of additional platelets. We expect that these data will provide insights into the differences in thrombogenicity between surfaces and we hope that they will provide information that can be exploited to purposefully passivate platelet-reactive artificial surfaces. They also provide a potential hypothesis to explain the loss of thrombogenicity that occurs with time after blood vessel injury by angioplasty or other insults (58-60), since Hatton et al. (61 ) reported that in rabbits fibrinogen saturates the denuded aortic surface 10 min after balloon injury deendothelialization at a level of 13 pmol/cm2, which corresponds to -2 X 106 molecules/25 AM2.
